Nitric oxide (NO S ) is an effective chain-breaking antioxidant in free radical-mediated lipid oxidation (LPO). It reacts rapidly with peroxyl radicals as a sacrificial chain-terminating antioxidant. The goal of this work was to determine the minimum threshold concentration of NO S required to inhibit Fe 2+ -induced cellular lipid peroxidation. Using oxygen consumption as a measure of LPO, we simultaneously measured nitric oxide and oxygen concentrations with NO S and O 2 electrodes. Ferrous iron and dioxygen were used to initiate LPO in docosahexaenoic acidenriched HL-60 and U937 cells. Bolus addition of NO S (1.5 AM) inhibited LPO when the NO S concentration was greater than 50 nM. Similarly, There is great interest in the role of nitric oxide (oxidonitrogen( S ) or NO S ) in biology because it can be a signalling, molecule, a toxin, a pro-oxidant, and a potential antioxidant. It is involved in signalling in vasodilatation [1 -4] and neurotransmission [5] , a toxin in the destruction of pathogens [6, 7] , and a precursor to oxidizing and nitrating species [8, 9] . However, its diverse chemistry and its biologic activity sometimes are seemingly contradictory. Nowhere is this contradiction more evident than in oxidative stress. Nitric oxide has been proposed to act as a pro-oxidant at high concentrations [10] or when it reacts with superoxide (O 2 SÀ ), forming the highly reactive peroxynitrite (ONOO À ) [11 -13]. On the other hand, NO S can also inhibit oxidation; NO S can terminate chain reactions during lipid peroxidation, as observed in model lipid systems [14, 15] , in low-density lipoprotein oxidation [16 -19], and in cells [20, 21] .
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Oxidative stress is a disruption in the cellular pro-oxidant antioxidant balance [22] . As the balance shifts toward prooxidants, potential damage in the form of oxidized DNA, proteins, and lipids can occur. Lipid peroxidation can be defined as the oxidative deterioration of lipids containing two or more carbon -carbon double bonds. The propensity of polyunsaturated fatty acids (PUFAs) to undergo lipid oxidation (LPO) is due to the bis-allylic methylene hydrogens, which are more susceptible to hydrogen abstraction by oxidants than fully saturated lipids [23] .
Lipid peroxidation has three major components: initiation, propagation, and termination [24] ,
LOO S ðpropagation cycleÞ; Nitric oxide can serve as a chain-terminating antioxidant by reacting with chain-carrying peroxyl radicals:
Nitric oxide can be produced both nonenzymatically and enzymatically. For example, under some physiological conditions (e.g., low pH), NO 2 À can be reduced to NO S nonenzymatically [26] :
The family of nitric oxide synthase (NOS) enzyme mediates the five-electron oxidation of l-arginine to l-citrulline producing NO S . There are three isoforms of NOS: neuronal (NOS1), inducible (NOS2), and endothelial (NOS3). Both NOS1 and NOS3 are constitutively expressed and are estimated to produce local NO S concentrations in the nanomolar range, whereas NOS2 activity is inducible and is estimated to produce concentrations of NO S in the micromolar range [27] .
Previous In the present work, our goal was to determine the minimum concentration of NO S required to inhibit cellular LPO. Iron(II) and dioxygen were used as an oxidative stress to initiate LPO in DHA-22:6N3-enriched HL-60 and U937 leukemia cells [28, 29] . To determine the minimum levels of NO S needed to blunt cellular LPO, we simultaneously measured the concentration of NO S and the rate of oxygen consumption.
Materials and methods

NO
S stock solution
Nitric oxide gas was either obtained from a nitric oxide gas tank or prepared from an acidified sodium nitrite solution [30, 31] . Because the nitric oxide from either source can be contaminated with other oxides of nitrogen, it was purified by passing it through NaOH (4 M) and then deionized (DI) water.
The purified NO S gas was then bubbled through a gas sampling bottle containing degassed DI water and stored.
Donor
The NONOate donor, (Z)-1-[N-(3-ammoniopropyl)-N-(npropyl)amino]diazen-1-ium-1,2-diolate (PAPA/NO), and Snitroso-N-acetyl-d,l-penicillamine (SNAP) were from Alexis (San Diego, CA, USA).
NO S and O 2 electrodes
For the bolus-addition experiments, simultaneous electrochemical measurements of nitric oxide and oxygen were made using an ISO-NO Mark II NO S measurement system (World Precision Instruments, Sarasota, FL, USA) and ISO 2 oxygen system. Data from these instruments were imported into a PC using a Duo18 data recording system (WPI). The data recording system allowed for measurements at 0.2-s intervals. Both the NO S and the O 2 probes were standardized daily according to the manufacturer's recommendations. The response time of the nitric oxide probe was rapid (<10 s equilibration to 1.5 AM NO S by bolus injection). For the donor experiments, the steady-state NO S concentrations produced through the degradation of the NONOate donors were determined using an Apollo 4000 free radical analyzer (World Precision Instruments). The NO S electrode was calibrated using two different techniques. The first method used bolus additions of increasing volumes of 50 nM NaNO 2 into 10 ml of reducing solution (0.1 M KI, 0.1 M H 2 SO 4 ). The production of NO S via the reduction of NaNO 2 is illustrated by the following equation:
The second calibration method uses bolus additions of a 150 AM SNAP and 540 AM EDTA solution into a 0.1 M copper sulfate solution. SNAP decomposes to NO S and a disulfide byproduct according to the following equation:
Regardless of the calibration method used, an electrode response plot is generated. The NO S electrode generally has a linear response from 25 to 2000 nM of which the slope of the line provides the current-to-concentration ratio for the electrode. At a range of 25 -400 nM the linear response of the electrode normally provides an r 2 value of 0.99. If the r value begins to deviate, the electrodes are inspected for tears in the membrane, which affect the response. The electrochemical signal from the O 2 electrode was calibrated using the signal difference from aerated water (approximately 250 AM) and an argon-purged aqueous solution (0 AM).
Cell culture
Human leukemia cells (HL-60, U937) were acquired from the American Type Culture Collection. Cells were grown in medium consisting of RPMI 1640 medium (Gibco) and 10% fetal bovine serum (10% FBS -RPMI) supplemented with lglutamine (2 mM) at 37-C, 5% CO 2 /95% air. Experiments were done in exponential growth phase. To alter the fatty acid profile of cells they were grown in 10% FBS -RPMI medium supplemented with 32 AM DHA-22:6N3 for 48 h [23] . [25] Lipid peroxidation measurements
HL-60
HL-60 cells were washed twice, first in RPMI 1640 medium and then in PBS by centrifugation (300g). Upon resuspension, cell density was adjusted (3 Â 10 6 cells/ml) for the LPO experiments [32, 33] . After baseline measurements of [O 2 ] and [NO S ] in the ISO-NO chamber, FeSO 4 (10 AM final concentration; 10 mM stock at pH 2.0) was introduced to induce lipid peroxidation. The pH of the cell suspension, 6.5, was not significantly affected by the injection. The pH of 6.5 was chosen to avoid problems of iron solubility and consequently the reactivity of ferrous iron [34] . All reactions were performed at 25-C with magnetic stirring.
U937
Cellular LPO was measured via the rate of consumption of oxygen using an oxygen electrode system [20, 21] NaCl at pH å 6.5 within a 1-ml NO S chamber. The chamber was then sealed and the electrodes were inserted. We used NO S donors to measure the antioxidant effect of NO S in ironinduced lipid peroxidation. The pH of both the Fe 2+ solution and the donor was adjusted from their respective storage solutions to pH 6.5 before addition to the system.
Results
To determine the level of nitric oxide needed to blunt lipid peroxidation we used a leukemia cell culture model system in which the cells were enriched with the unsaturated fatty acid DHA-22:6N3 [23] . This enrichment results in the cells being more oxidizable, providing an ideal system to study cellular lipid oxidation. We used two complementary approaches to identify the minimum level of [ 
The rate of this process is governed by a rare, third-order rate constant k = 2.4 Â 10 6 M À2 s À1 at 37-C [35] ; oxygen concentration enters the rate equation as a first-order term, nitric oxide concentration as a second-order term. Analysis of the electrode data for the disappearance of NO S vs time showed that the presence of neither cells nor ferrous iron produced a major change in the rate of disappearance of NO S (Table 1) . However, NO S disappeared rapidly when cells were undergoing significant lipid peroxidation; Fig. 1 depicts representative experiments in which NO S and Fe 2+ were injected in rapid succession. Consistent with previous observations [33, 36] , the introduction of ferrous iron results in a rapid initiation of cellular lipid oxidation as seen by uptake of oxygen. As observed in model systems and LDL oxidation [14, 16] as well as cellular systems [20, 21] , when a bolus of NO S (1.5 AM) was introduced, this rapid uptake of oxygen was delayed until the concentration of NO S became very low, and then the rate of oxygen uptake accelerated.
To arrive at an estimate of the concentration of NO S below which rapid oxygen uptake ensued, we plotted the data of Fig.  1 e Fe 2+ added was 10 AM, as in Fig. 1 . S in many tissues [37 -40] .
As an additional way to view the results, we grouped sets of similar rates, as observed in rate-inhibitor plots from these experiments, into bins (Fig. 2B) . We found that the peroxidation rate is substantially higher when [NO S ] was <50 nM.
These results suggest that only low nanomolar levels of nitric oxide are needed to serve as an effective lipid antioxidant. The experiments above using bolus addition of stock solutions of NO and is in general dependent on temperature and pH [41] . Under our experimental conditions the half-life of PAPA/NO is å20 min (data not shown). In the experiments using PAPA/NO as a continuous source of NO S , we used DHA-enriched U937 cells, a cell line very similar to HL-60 cells; we chose these cells because the myeloperoxidase of HL-60 could accelerate the oxidation of NO S [42] , although control experiments indicated this not to be a problem (data not shown).
Two representative experiments, using PAPA/NO as a NO S donor, are presented in Fig. 3 (data for all experiments are summarized in Table 2 ); Fig. 3A shows an experiment in which the maximum level of NO S reached only 20 nM, whereas in 
Discussion
Nitric oxide has a rich chemistry that includes its rapid reaction with peroxyl radicals (Reaction (6)). This chaintermination reaction has a result similar to that of typical donor antioxidants such as vitamin E in that the chain carrying peroxyl radical (LOO S ) is removed. Thus, if the covalent product, LOONjO, is not very reactive, then NO S will serve as a chain-breaking antioxidant. The discovery that NO S can be an antioxidant in LDL oxidation [16] has generated interest in the importance and mechanism of its antioxidant action. In this work we have used in vitro cell models to estimate the minimum levels of NO S needed to inhibit Fe 2+ -O 2 -mediated lipid oxidation.
We have observed that quite low levels of NO S are required to suppress LPO. When a bolus of NO S (å1.5 AM) was introduced into rapidly peroxidizing cells, lipid peroxidation was blunted; at least 50 nM NO S was needed to maintain a low rate of LPO, preventing rapid LPO. Interestingly when a nitric oxide donor was used to generate low steady-state levels of NO S , a lower level of NO S (greater than å15 nM) was required. However, the PAPA/NO-donor experiments reveal two phases for the antioxidant action of NO S . As observed here and in our previous work [20, S was required to keep lipid oxidation processes in check. These somewhat different threshold levels of NO S can be understood by examining the rate of lipid peroxidation once it accelerates. In the bolus experiments, the rate of oxygen uptake is much greater than in the donor experiments, once acceleration occurs. This is consistent with a greater oxidative stress, i.e., a greater rate of initiation in the bolus experiments, thus a higher level of NO S is required.
These experiments demonstrate that only very low nanomolar levels of NO S are required to blunt cellular lipid oxidation.
Ambient levels of NO S in vivo are estimated to be approximately these concentrations; in vivo concentrations would be higher during signalling events or during particular pathologies. These results suggest that NO S will be an effective antioxidant in vivo because only very low levels are required. 
